← Back to IRD

Opus Genetics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Sep 2025Filed 12/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/11/2025Mar 2024Filed 12/11/2025
$0.8$2.2$3.1$2.9$4.4$3.9$1.1$1.7
−$8.1−$66−$17−$7.4−$8.2−$7.5−$7.8−$7.1
−$0.14−$0.75−$0.25−$0.12−$0.24−$0.29−$0.30−$0.29
11187716334262625

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.